Status:
UNKNOWN
Clinical Outcome in Patients With Syringomyelia（COPSM）
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Syringomyelia/Hydromyelia
Eligibility:
All Genders
Up to 80 years
Brief Summary
The aim of this study is to determine the clinical spectrum and natural progression of Syringomyelia (SM) and related disorders in a prospective single center study, identify digital, imaging and mole...
Detailed Description
Syringomyelia is a chronic central spinal cord injury, which is characterized by dilation of the central canal of the spinal cord. At present, the treatment of syringomyelia is mainly through surgical...
Eligibility Criteria
Inclusion
- patients who was diagnosed as syringomyelia including: Chiari malformation， Basilar Impression， subarachnoid obstruction， patient not received surgical or interventional treatment before， patient willing and able to participate in the registry，
- Hydrocephalus or other neurodegenerative disease and normal subjects.
Exclusion
- patient received surgical treatment or interventional treatment before
- patient is pregnant
- patient unable to complete follow-up
- patient with other spinal lesions
- other nervous system diseases
Key Trial Info
Start Date :
April 16 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04856839
Start Date
April 16 2021
End Date
April 30 2025
Last Update
June 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital
Beijing, Beijing Municipality, China, 100032